Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, has completed its previously announced acquisition of Mobidiag Oy, an innovator in near-patient, acute care molecular diagnostic testing, for an enterprise value of approximately $808 million. Mobidiag provides near-patient, molecular diagnostic instruments and tests for acute care conditions including gastrointestinal and respiratory infections, antimicrobial resistance management, and healthcare associated infections.
Read the full article: Hologic Completes Acquisition of Mobidiag //
Source: https://www.businesswire.com/news/home/20210617005517/en/Hologic-Completes-Acquisition-of-Mobidiag